Search For "developed by"
Japan to approve use of AstraZeneca, Moderna COVID-19 vaccines
Updated : 5 years ago IST
Tokyo [Japan], May 21 (ANI): The Japanese government on Friday gave the green signal for two more COVID-19 vaccines -- those developed by AstraZeneca and Moderna pharmaceutical giants -- to be added to the nation's vaccine portfolio, Kyodo news reported.
Read More
Both Pfizer, Moderna vaccines effective on B.1.617 COVID-19 strain: US Stu
Updated : 5 years ago IST
Washington [US], May 19 (ANI): COVID-19 vaccines developed by Pfizer and Moderna work against B.1.617 variant of the virus that was first identified in India, according to a new study.
Read More
Haryana to purchase anti-COVID drug developed by DRDO
Updated : 5 years ago IST
Chandigarh (Haryana) [India], May 17 (ANI): Haryana will purchase anti-COVID drug 2DG developed by DRDO for treatment of coroanvirus patients, state Health Minister Anil Vij said.
Read More
DRDO's anti-COVID drug will be available to hospitals across country from
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): After the first batch of anti-COVID drug 2-DG developed by DRDO was released by Defence Minister Rajnath Singh here, it will be available only to AIIMS, Armed Forces Hospitals, DRDO hospitals and other places in need. While the drug shall be made available to
Read More
Rajnath terms DRDO's anti-COVID drug 'ray of hope', says it exemplifies In
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): After releasing the first batch of anti-COVID drug 2-DG developed by the Defence Research and Development Organisation (DRDO), Defence Minister Rajnath Singh on Monday termed the drug as a new ray of hope and said this is a great example of India's scienti
Read More
DRDO's anti-COVID drug 2-DG will reduce recovery time, oxygen dependency,
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO). Read More
Rajnath Singh, Harsh Vardhan release first batch of DRDO's anti-COVID drug
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
Read More
Rajnath Singh to release first batch of DRDO's 2DG medicine for treating C
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Read More
Study reveals drivers with shift work sleep disorder 3 times more likely t
Updated : 5 years ago IST
Missouri [US], May 15 (ANI): According to researchers, people who suffer from 'shift work sleep disorder', a condition developed by working late at night, especially from 11 pm to 7 am, are three times more likely to be involved in an accident.
Read More
PM CARES Fund approves procurement of 1.5 lakh Oxycare Systems developed b
Updated : 5 years ago IST
New Delhi [India], May 12 (ANI): The PM CARES Fund has approved procurement of 1,50,000 units of Oxycare System developed by the Defence Research Development Organisation at a cost of Rs 322.5 crores, the DRDO informed on Wednesday.
Read More
Global sales of Celltrion's COVID-19 antibody-drug Regkirona begin
Updated : 5 years ago IST
Seoul [South Korea], May 12 (ANI/Global Economic): Worldwide sales of Regkirona (active ingredient: regdanvimab), a COVID-19 antibody drug developed by South Korean biopharmaceutical company Celltrion Inc, has begun.
Read More
DCGI nods anti-COVID drug developed by DRDO for emergency use
Updated : 5 years ago IST
New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
Read More